Orthopedic Surgeons at Greater Risk of Malpractice Claims for Treatment of Primary Malignant Bone and Soft…

StudyJournal of surgical oncology· May 2025

Orthopedic Surgeons at Greater Risk of Malpractice Claims for Treatment of Primary Malignant Bone and Soft Tissue Tumors Compared With Metastatic Bone Disease.

Serkan Bayram, Muhammed Oduncu, Caner Beşkoç, Yusuf Atan

OrthopedicsStudyClinical practiceQ2IF 1.9

Malpractice claims accepted in 16% of primary bone/soft tissue sarcoma cases, none for metastatic disease.

Orthopedic Surgeons at Greater Risk of Malpractice Claims for Treatment of Primary Malignant Bone and Soft Tissue Tumors Compared With Metastatic Bone Disease.

Serkan Bayram … Yusuf Atan

Journal of surgical oncology · May 2025 · Q2 in General Medicine

Background

The aim of this study was to examine cases of malpractice litigation in primary sarcoma and metastatic bone disease in orthopedic oncology, to identify the areas in which orthopedic surgeons may be guilty of negligence, and to make them aware of this.

Methods

The inclusion and exclusion criteria of the study resulted in the inclusion of 70 cases of primary bone and soft tissue sarcoma and 36 cases of metastatic bone disease.

n = 70 cases

16%

Results

16%

16% of primary sarcoma malpractice cases were upheld, versus 0% for metastatic bone disease.

n = 70 cases

More results

A total of 47 primary tumors were bone sarcoma and 23 were soft tissue sarcoma.

Nevertheless, no evidence of malpractice was identified among the patients with metastatic bone disease (p = 0.012).

More results

Orthopedists (44 of 85 defendants), pathologists (14 of 85 defendants), and radiologists (7 of 85 defendants) were the most common defendants in primary sarcoma malpractice cases.

“

Conclusion

Analysis of our cases suggests that malpractice claims are more likely filed against orthopedic surgeons for the treatment of primary malignant bone and soft tissue tumors than for metastatic bone disease.

Orthopedic Surgeons at Greater Risk of Malpractice Claims for Treatment of Primary Malignant Bone and Soft Tissue Tumors Compared With Metastatic Bone Disease.

Orthopedic Surgeons at Greater Risk of Malpractice Claims for Treatment of Primary Malignant Bone and Soft Tissue Tumors Compared With Metastatic Bone Disease.

Related papers